vTv Therapeutics Inc. (VTVT) › Operating IncomevTv Therapeutics Inc. (VTVT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$35.83M2014: -$28.90M2015: -$38.14M2016: -$55.02M2017: -$50.68M2018: -$19.82M2019: -$20.89M2020: -$11.85M2021: -$21.66M2022: -$22.54M2023: -$25.50M2024: -$24.18M2025: -$32.81M-$32.81M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$32.81M-35.7%2024-$24.18M+5.2%2023-$25.50M-13.1%2022-$22.54M-4.1%2021-$21.66M-82.8%2020-$11.85M+43.3%2019-$20.89M-5.4%2018-$19.82M+60.9%2017-$50.68M+7.9%2016-$55.02M-44.3%2015-$38.14M-32.0%2014-$28.90M+19.4%2013-$35.83M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share